Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Completed Phase 1 Interventional

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

ClinicalTrials.gov ID: NCT01485731

Public ClinicalTrials.gov record NCT01485731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1 Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)

Study identification

NCT ID
NCT01485731
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
University of Miami
Other
Enrollment
8 participants

Conditions and interventions

Interventions

  • Nelfinavir Drug
  • Cisplatin Drug
  • Pelvic External Beam Radiation Therapy Radiation
  • Brachytherapy Radiation
  • Pharmacokinetic Sampling Procedure
  • Cervical Biopsy Procedure
  • Pelvic Examination Procedure
  • Pap Smear Procedure
  • Audiogram Procedure
  • Proctoscopy Procedure
  • Cytoscopy Procedure
  • Renal Ultrasound Procedure
  • CT Scan Procedure
  • Whole Body PET/CT Scan Procedure

Drug · Radiation · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2011
Primary completion
Jan 31, 2015
Completion
Jan 31, 2015
Last update posted
Jun 2, 2015

2012 – 2015

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
University of Miami Miami Florida 33136 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01485731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2015 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01485731 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →